Latest Insider Transactions at Inspire Medical Systems, Inc. (INSP)
This section provides a real-time view of insider transactions for Inspire Medical Systems, Inc. (INSP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inspire Medical Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inspire Medical Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
8,703
-12.68%
|
$1,688,382
$194.53 P/Share
|
|
Nov 01
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,703
+18.96%
|
$487,368
$56.58 P/Share
|
|
Oct 14
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
115
+2.61%
|
$24,150
$210.46 P/Share
|
|
Oct 14
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
79
+3.45%
|
$16,590
$210.46 P/Share
|
|
Oct 14
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
68
+0.33%
|
$14,280
$210.46 P/Share
|
|
Oct 14
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
77
+2.99%
|
$16,170
$210.46 P/Share
|
|
Sep 09
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
31
-0.27%
|
$6,665
$215.0 P/Share
|
|
Sep 09
2024
|
Shawn Mc Cormick Director |
SELL
Open market or private sale
|
Direct |
800
-3.34%
|
$176,000
$220.0 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,000
-16.18%
|
$945,000
$189.6 P/Share
|
|
Aug 22
2024
|
John Rondoni Chief Technology Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+23.39%
|
$355,000
$71.0 P/Share
|
|
Aug 16
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
4,861
-25.9%
|
$913,868
$188.47 P/Share
|
|
Aug 16
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,861
+38.04%
|
$204,162
$42.15 P/Share
|
|
Aug 15
2024
|
Randy Ban Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
16,139
-22.8%
|
$3,098,688
$192.1 P/Share
|
|
Aug 15
2024
|
Randy Ban Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,139
+45.68%
|
$677,838
$42.15 P/Share
|
|
Aug 14
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
8,537
+26.29%
|
$0
$0.94 P/Share
|
|
Jul 31
2024
|
Melissa Mann Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,190
+50.0%
|
-
|
|
Jul 15
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
117
+4.61%
|
$16,146
$138.58 P/Share
|
|
Jul 15
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
154
+3.56%
|
$21,252
$138.58 P/Share
|
|
Jul 15
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
32
+1.48%
|
$4,416
$138.58 P/Share
|
|
Jul 15
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
103
+0.5%
|
$14,214
$138.58 P/Share
|
|
May 31
2024
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Bona fide gift
|
Indirect |
3,000
-2.59%
|
-
|
|
May 29
2024
|
Charisse Y Sparks Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
64
-1.73%
|
-
|
|
May 10
2024
|
Shawn Mc Cormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+13.96%
|
$0
$0.94 P/Share
|
|
May 02
2024
|
Cynthia Burks Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+34.08%
|
-
|
|
May 02
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+15.12%
|
-
|
|
May 02
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.41%
|
-
|
|
May 02
2024
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+3.24%
|
-
|
|
May 02
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+25.41%
|
-
|
|
May 02
2024
|
Myriam Curet Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+25.43%
|
-
|
|
May 02
2024
|
Shawn Mc Cormick Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+5.26%
|
-
|
|
May 02
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
716
+23.69%
|
-
|
|
Apr 29
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,175
+3.19%
|
$282,000
$240.68 P/Share
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
BUY
Bona fide gift
|
Indirect |
500
+8.47%
|
-
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
SELL
Bona fide gift
|
Direct |
500
-1.77%
|
-
|
|
Apr 17
2024
|
Richard Buchholz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-34.67%
|
$3,450,000
$230.03 P/Share
|
|
Apr 12
2024
|
Shelley G. Broader Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+4.22%
|
$16,170
$231.74 P/Share
|
|
Apr 12
2024
|
Casey M Tansey Director |
BUY
Grant, award, or other acquisition
|
Direct |
62
+0.32%
|
$14,322
$231.74 P/Share
|
|
Apr 12
2024
|
Gary Lee Ellis Director |
BUY
Grant, award, or other acquisition
|
Direct |
70
+2.07%
|
$16,170
$231.74 P/Share
|
|
Apr 12
2024
|
Marilyn C Nelson Director |
BUY
Grant, award, or other acquisition
|
Direct |
107
+0.31%
|
$24,717
$231.74 P/Share
|
|
Apr 12
2024
|
Georgia Melenikiotou Director |
BUY
Grant, award, or other acquisition
|
Direct |
56
+3.88%
|
$12,936
$231.74 P/Share
|
|
Apr 01
2024
|
Timothy P. Herbert CEO, President & Chairperson |
SELL
Open market or private sale
|
Indirect |
40,000
-5.15%
|
$8,280,000
$207.6 P/Share
|
|
Apr 01
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
32
-0.29%
|
$6,816
$213.99 P/Share
|
|
Apr 01
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
296
+2.64%
|
$4,736
$16.0 P/Share
|
|
Apr 01
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,273
+8.7%
|
$52,368
$16.0 P/Share
|
|
Mar 27
2024
|
Marilyn C Nelson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,243
+5.07%
|
$366,459
$113.64 P/Share
|
|
Mar 25
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-2.49%
|
$109,138
$197.81 P/Share
|
|
Mar 25
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.2%
|
$16,000
$16.0 P/Share
|
|
Mar 22
2024
|
John Rondoni Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
4,387
-10.05%
|
$851,078
$194.46 P/Share
|
|
Mar 18
2024
|
Jerry C Griffin Director |
SELL
Open market or private sale
|
Direct |
554
-2.59%
|
$106,922
$193.53 P/Share
|
|
Mar 18
2024
|
Jerry C Griffin Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+8.52%
|
$16,000
$16.0 P/Share
|